Supartz
Supartz is a Class III device made by Pavan Trading Ltd, approved under FDA PMA P980044 on 24 Jan 2001 and listed in FDA GUDID since 5 Apr 2018 (UDI-DI 05060548950057), active as of 22 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05060548950057 | Date5 Apr 2018 | StatusListed |
| United States | FDA PMAAPPR | NumberP980044 | Date24 Jan 2001 | StatusActive |
Official records
- AccessGUDID record 05060548950057
- FDA PMA database P980044
Across registries
- FDA PMA P980044 decided 24 Jan 2001 Active
- FDA GUDID UDI-DI 05060548950057 listed 5 Apr 2018 Listed
Timeline
- Approved FDA PMA P980044
- Listed FDA GUDID 05060548950057
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic name
- Synovial fluid supplementation medium
- Primary DI / UDI-DI
- 05060548950057
- PMA number
- FDA product code
- MOZ
- GMDN term
- Synovial fluid supplementation medium
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- Hyalgan Acid, Hyaluronic, Intraarticular by Fidia Farmaceutici S.p.A.
- Euflexxa (1% Sodium Hyaluronate) by Ferring Pharmaceuticals, Inc.
- Durolane by BIOVENTUS LLC
- Gel-Syn Acid, Hyaluronic, Intraarticular by Ibsa Institut Biochimique SA
- Monovisc Injectable Intra-Articular Device by Anika Therapeutics, Inc.
- SYNOJOYNT by Mesoblast
- TriVisc by Channel-Markers Medical, LLC
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.
- TRILURON by Fidia Farmaceutici S.p.A.
- Gel-One by Seikagaku Corp.